Persistent High Levels Of Circulating Effector Memory T Cells And Anti-Nuclear Antibodies In Metastatic Melanoma Patients Who Experience Durable Crs To Immunotherapy After The Cessation Of Treatment.

Megan Wheelden,Jeremy Scott Haley,Todd D. Schell,Kathleen M. Kokolus,Diane Hershock,Carol Mallon,Heath B. Mackley,Jeffrey Sivik,Joseph J. Drabick

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 0|浏览29

暂无评分

摘要

e21576Background: Checkpoint blockade therapies have dramatically improved the prognosis for metastatic melanoma patients, with overall response rates reported as high as 35%. These regimens have s...

查看译文

关键词

metastatic melanoma patients,immunotherapy,antibodies,anti-nuclear

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要